References
- AIDSinfo Drug Database. (2016). Retrieved from http://aidsinfo.nih.gov/drugs
- California HealthCare Foundation (CHCF). (2015). Better Shop around: Out-of-Pocket prescription drug costs in covered California Plans. Retrieved from CHCF http://www.chcf.org/~/media/MEDIA%20LIBRARY%20Files/PDF/PDF%20B/PDF%20BetterShopDrugsCoveredCA.pdf
- Centers for Disease Control and Prevention (CDC). (2016). HIV in the United States: At a Glance. Retrieved from CDC https://www.cdc.gov/hiv/pdf/statistics/overview/hiv-at-a-glance-factsheet.pdf
- Cihlar, T., & Fordyce, M. (2016). Current status and prospects of HIV treatment. Current Opinion in Virology, 18, 50–56. doi:10.1016/j.coviro.2016.03.004
- Gordon. (2015). AB-339 Health care coverage: Outpatient prescription drugs. Retrieved from California leginfo database http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id = 201520160AB339
- Jacobs, D. B., & Sommers, B. D. (2015). Using drugs to discriminate—adverse selection in the insurance marketplace. New England Journal of Medicine, 372(5), 399–402. doi:10.1056/NEJMp1411376
- Jarcho, J. A. (2014). Single-pill combination regimens for treatment of HIV-1 infection. New England Journal of Medicine, 371(3), 248–259. doi: 10.1056/NEJMct1215532
- Kates, J., Garfield, R., Young, K., Quinn, K., Frazier, E., & Skarbinsk, J. (2014). Assessing the impact of the affordable care act on health insurance coverage of people with HIV. Kaiser Family Foundation. Retrieved from http://kff.org/hivaids/issue-brief/assessing-the-impact-of-the-affordable-care-act-on-health-insurance-coverage-of-people-with-hiv
- Micromedex Solutions Drug database. Retrieved from http://www.micromedexsolutions.com/
- Project Inform. (2015). Covered California’s 2016 Formularies: An analysis of the drugs per tier in all 12 health plans that are available for treating and preventing HIV. Retrieved from http://www.projectinform.org/pdf/CCformularies.pdf
- Solem, C. T., Snedecor, S. J., Khachatryan, A., Nedrow, K., Tawadrous, M., Chambers, R., … Simpson, K. (2014). Cost of treatment in a US commercially insured, HIV-1–Infected POPULATION. PloS one, 9(5), e98152. doi: 10.1371/journal.pone.0098152
- Sweet, D. E., Altice, F. L., Cohen, C. J., & Vandewalle, B. (2016). Cost-effectiveness of single-versus generic multiple-tablet regimens for treatment of HIV-1 infection in the United States. PloS one, 11(1), e0147821. doi: 10.1371/journal.pone.0147821
- Truong, W. R., Schafer, J. J., & Short, W. R. (2015). Once-daily, single-tablet regimens for the treatment of HIV-1 infection. Pharmacy and Therapeutics, 40(1), 44. PMCID:PMC4296592
- Walensky, R. P., Sax, P. E., Nakamura, Y. M., Weinstein, M. C., Pei, P. P., Freedberg, K. A., … Schackman, B. R. (2013). Economic savings versus health losses: The cost-effectiveness of generic antiretroviral therapy in the United States. Annals of Internal Medicine, 158(2), 84–92. doi:10.7326/0003-4819-158-2-201301150-00002